期刊文献+

代谢综合征合并结直肠癌患者脂肪组织IGF-Ⅰ、ERK、GLUT4 mRNA表达水平的变化及临床意义 被引量:2

The significance of genetic expression of IGF-Ⅰ, ERK, and GLUT4 in adipose tissue of patients with metabolic syndrome and colorectal cancer and its significance
原文传递
导出
摘要 分析代谢综合征合并结直肠癌患者大网膜脂肪组织中胰岛素样生长因子Ⅰ(IGF-Ⅰ)、细胞外信号调节激酶(ERK)和葡萄糖转运蛋白4(GLUT4)mRNA表达水平。采用RT-PCR技术检测患者大网膜脂肪组织中IGF-Ⅰ、ERK和GLUT4的mRNA表达水平。结果显示:(1)代谢综合征组大网膜脂肪组织IGF-Ⅰ和ERK的mRNA表达显著高于对照组(P〈0.01),其中结直肠癌亚组高于非肿瘤亚组(P〈0.01)。GLUT4的mRNA表达显著低于对照组(P〈0.01)。(2)ERK与IGF-Ⅰ的mRNA表达呈显著正相关(r=0.608,P〈0.01)。血清空腹胰岛素与ERK、IGF-Ⅰ的mRNA表达呈显著正相关(r=0.538、0.439,P〈0.01),与GLUT4呈显著负相关(r=-0.457,P〈0.01)。IGF-Ⅰ和ERK联合与代谢综合征患者并发结直肠癌有关,GLUT4在代谢综合征中的表达下调可能与代谢综合征脂肪组织发生胰岛素抵抗有关。 To explore the mRNA expression of insulin-like growth factor-Ⅰ(IGF-Ⅰ), extracellular signal regulated kinase(ERK), and glucose transporter 4(GLUT4)in greater omental adipose tissue of patients with metabolic syndrome and colorectal cancer. The mRNA expression of IGF-Ⅰ, ERK, and GLUT4 in greater omental adipose tissue of the subjects was measured by RT-PCR.(1)The mRNA expression level of IGF-Ⅰ and ERK in the metabolic syndrome group was significantly higher than that in the control group(P〈0.01), while in colorectal cancer subgroup the expression was significantly higher than that in the non-colorectal cancer subgroup(P〈0.01).The expression of GLUT4 was obviously lowered(P〈0.01).(2)The expression of ERK was positively correlated with that of IGF-Ⅰ(r= 0.608, P〈0.01).The fasting insulin was positively correlated with the expression of ERK and IGF-Ⅰ(r =0.538, 0.439, P〈0.01), and negatively with that of GLUT4(r=-0.457,P〈0.01). There may be relationship between ERK plus IGF-Ⅰ and metabolic syndrome complicated with colorectal cancer. The lowered GLUT4 expression may be related to insulin resistance in metabolic syndrome.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第10期876-878,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 代谢综合征 结直肠癌 胰岛素样生长因子Ⅰ 细胞外信号调节激酶 葡萄糖转运蛋白4 Metabolic syndrome Colorectal cancer Insulin-like growth factor-Ⅰ Extracellular signal regulated kinase Glucose transporter 4
  • 相关文献

参考文献3

二级参考文献43

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3063
  • 2Beck-Nielsen H, Hother-Nielsen O. Obesity in type 2 diabetes mellitus. Diabetes Mellitus. Edited by LeRoith D, Taylor SI, Olefsky JM. Philadelphia:Lippincott Williams & Wilkins, 2004: 857-868.
  • 3Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev, 1996,5:1013-1015.
  • 4Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst,2004, 96:546-553.
  • 5Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med, 2003, 348: 1625-1638.
  • 6Halperin RO, Sesso HD, Ma J, et al. Dyslipidemia and the risk of incident hypertension in men. Hypertension ,2006, 47:45-50.
  • 7Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer, 2006, 107:28-36.
  • 8Asakawa H,Tokunnaga K,KAWawakami F.Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients.Diabetes Res Clin Pract 2002;55(2):139-149
  • 9Nelson TL,Vogle GP,Pedersen NL,et al.Genetic and environmental influences on body fat distribution,fasting insulin levels and CVD:are the influences shared? Twin Res 2000;3(1):43-50
  • 10Boden G.Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.Diabetes 1997;46(3):3-10

共引文献85

同被引文献20

  • 1吕炳建,来茂德.代谢综合征、胰岛素抵抗与结直肠癌[J].中华病理学杂志,2006,35(2):110-112. 被引量:10
  • 2Schally AV,Szepeshazi K,Nagy A,et al. New approachesto therapy of cancers of the stomach, colon and pancreasbased on peptide analogs[J], Cell Mol Life Sci,2004, 61(9):1042-1068.
  • 3Galassi A, Reynolds K,He J. Metabolic syndrome and risk ofcardiovascular disease:a meta-analysis[J]. Am J Med,2006,119(10):812-819.
  • 4Bowers K, Albanes D,Limburg P,et al. A prospective studyof anthropometric and clinical measurements associated withinsulin resistance syndrome and colorectal cancer in malesmokers[J]. Am J Epidemiol,2006,164(7) :652-664.
  • 5Stocks T,Lukanova A,Bjorge T, et al. Metabolic factors andthe risk of colorectal cancer in 580,000 men and women inthe metabolic syndrome and cancer project (Me-Can) [J],Cancer,2011,117(11) :2398-2407.
  • 6Matthews CE, Sui X> Lamonte MJ, et al. Metabolic syn-drome and risk of death from cancers of the digestive sys-tem[J]. Metabolism,2010,59(8) : 1231-1239.
  • 7Pelucchi C,Negri E,Talamini R,et al. Metabolic syndrome isassociated with colorectal cancer in men[J]. Eur J Cancer,2010,46(10):1866-1872.
  • 8Osaki Y,Taniguchi S,Tahara A,et al. Metabolic syn-drome and incidence of liver and breast cancers in Japan[J]. Cancer Epidemiol,2012,36(2) : 141-147.
  • 9Inoue M,Noda M,Kurahashi N,et al. Impact of metabolicfactors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan [J]. Eur JCancer Prev,2009,18(3) :240-247.
  • 10Kabat GC,Kim MY,Peters U,et al. A longitudinal studyof the Metabolic syndrome and risk of colorectal cancer inpostmenopausal women[J], Eur J Cancer Prev, 2012 , 21(4).326-332.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部